Literature DB >> 29697767

Acquisition of Multidrug-resistant Organisms in the Absence of Antimicrobials.

Erika M C D'Agata1, Aby Varu2, Sara F Geffert1, Rafael Araos3, Susan Mitchell4, Aaron Situ2, Chris Cameron2.   

Abstract

A nested case-control study among 137 nursing home residents who did not receive antimicrobials, of whom 44 acquired a multidrug-resistant organism, was performed. Risk factors for acquisition included gastrointestinal medications that affect the gut microbiome, number of visits from healthcare workers, pressure ulcers, and not residing in a dementia unit.

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29697767      PMCID： PMC6186851          DOI： 10.1093/cid/ciy358

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  11 in total

1.  High rate of false-negative results of the rectal swab culture method in detection of gastrointestinal colonization with vancomycin-resistant enterococci.

Authors:  Erika M C D'Agata; Shiva Gautam; William K Green; Yi-Wei Tang
Journal:  Clin Infect Dis       Date:  2001-12-04       Impact factor: 9.079

2.  Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation.

Authors:  Les Dethlefsen; David A Relman
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-16       Impact factor: 11.205

3.  Diagnostic accuracy of surveillance cultures to detect gastrointestinal colonization with multidrug-resistant gram-negative bacteria.

Authors:  Graham M Snyder; Erika M C D'Agata
Journal:  Am J Infect Control       Date:  2011-09-17       Impact factor: 2.918

4.  Transmission of Methicillin-Resistant Staphylococcus aureus (MRSA) to Healthcare Worker Gowns and Gloves During Care of Nursing Home Residents.

Authors:  Mary-Claire Roghmann; J Kristie Johnson; John D Sorkin; Patricia Langenberg; Alison Lydecker; Brian Sorace; Lauren Levy; Lona Mody
Journal:  Infect Control Hosp Epidemiol       Date:  2015-05-26       Impact factor: 3.254

Review 5.  Lessons from the Environmental Antibiotic Resistome.

Authors:  Matthew D Surette; Gerard D Wright
Journal:  Annu Rev Microbiol       Date:  2017-06-28       Impact factor: 15.500

6.  Systematic review: human gut dysbiosis induced by non-antibiotic prescription medications.

Authors:  Q Le Bastard; G A Al-Ghalith; M Grégoire; G Chapelet; F Javaudin; E Dailly; E Batard; D Knights; E Montassier
Journal:  Aliment Pharmacol Ther       Date:  2017-12-05       Impact factor: 8.171

7.  Infection management and multidrug-resistant organisms in nursing home residents with advanced dementia.

Authors:  Susan L Mitchell; Michele L Shaffer; Mark B Loeb; Jane L Givens; Daniel Habtemariam; Dan K Kiely; Erika D'Agata
Journal:  JAMA Intern Med       Date:  2014-10       Impact factor: 21.873

Review 8.  Microbiota-mediated colonization resistance against intestinal pathogens.

Authors:  Charlie G Buffie; Eric G Pamer
Journal:  Nat Rev Immunol       Date:  2013-10-07       Impact factor: 53.106

9.  Multidrug-resistant gram-negative bacteria at a long-term care facility: assessment of residents, healthcare workers, and inanimate surfaces.

Authors:  Erin O'Fallon; Robert Schreiber; Ruth Kandel; Erika M C D'Agata
Journal:  Infect Control Hosp Epidemiol       Date:  2009-12       Impact factor: 3.254

10.  The study of pathogen resistance and antimicrobial use in dementia: study design and methodology.

Authors:  Susan L Mitchell; Michele L Shaffer; Dan K Kiely; Jane L Givens; Erika D'Agata
Journal:  Arch Gerontol Geriatr       Date:  2012-08-25       Impact factor: 3.250
View more
  1 in total

1.  Predicting probability of perirectal colonization with carbapenem-resistant Enterobacteriaceae (CRE) and other carbapenem-resistant organisms (CROs) at hospital unit admission.

Authors:  Katherine E Goodman; Patricia J Simner; Eili Y Klein; Abida Q Kazmi; Avinash Gadala; Matthew F Toerper; Scott Levin; Pranita D Tamma; Clare Rock; Sara E Cosgrove; Lisa L Maragakis; Aaron M Milstone
Journal:  Infect Control Hosp Epidemiol       Date:  2019-03-27       Impact factor: 3.254
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.